This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Junmei Wang in T Cell Reprogramming
Introduction
Junmei Wang is an accomplished inventor based in Houston, TX. She has made significant contributions to the field of immunology, particularly in the reprogramming of effector T cells. Her innovative work has the potential to advance cancer treatment methodologies.
Latest Patents
Junmei Wang holds a patent titled "Use of histone modifiers to reprogram effector T cells." This patent outlines methods for reprogramming effector T cells to a central memory phenotype. The process involves culturing the effector T cells with a histone deacetylase inhibitor (HDACi) and IL-21. Furthermore, the patent provides methods for treating cancer by administering the central memory T cells. She has 1 patent to her name.
Career Highlights
Junmei Wang is affiliated with the University of Texas System, where she conducts her research and development. Her work is pivotal in exploring new avenues for cancer therapies through T cell manipulation.
Collaborations
Junmei collaborates with Cassian Yee, a fellow researcher in the field. Their partnership enhances the research efforts aimed at improving cancer treatment strategies.
Conclusion
Junmei Wang's innovative approaches in T cell reprogramming represent a significant advancement in cancer treatment. Her contributions are paving the way for future breakthroughs in immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile